IGFBP1 Polyclonal Antibody

IGFBP1 Polyclonal Antibody

The IGFBP1 Polyclonal Antibody is a highly specific and sensitive antibody that has been developed for the detection of insulin-like growth factor binding protein 1 (IGFBP1) in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human IGFBP1. The resulting polyclonal antibody has been purified using protein A affinity chromatography and is suitable for use in a variety of applications, including Western blotting, immunohistochemistry, and ELISA.

The IGFBP1 Polyclonal Antibody has been extensively validated for its specificity and sensitivity. It has been shown to recognize human IGFBP1 with high affinity and does not cross-react with other related proteins. This antibody has been tested in a variety of biological samples, including serum, plasma, and tissue lysates, and has been shown to detect endogenous levels of IGFBP1.

The IGFBP1 Polyclonal Antibody is a valuable tool for researchers studying the role of IGFBP1 in various physiological and pathological processes. IGFBP1 is a member of the insulin-like growth factor binding protein family and plays a critical role in regulating the bioavailability and activity of insulin-like growth factors. Dysregulation of IGFBP1 has been implicated in a variety of diseases, including diabetes, cancer, and cardiovascular disease. The ability to accurately detect and quantify IGFBP1 levels in biological samples is therefore essential for understanding the underlying mechanisms of these diseases.

In summary, the IGFBP1 Polyclonal Antibody is a highly specific and sensitive antibody that is suitable for use in a variety of applications. Its ability to accurately detect and quantify IGFBP1 levels in biological samples makes it a valuable tool for researchers studying the role of IGFBP1 in various physiological and pathological processes.